benzofuran has been researched along with Parkinson Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Olotu, FA; Soliman, MES; Soremekun, OS; Subair, TI | 1 |
Ai, N; Chong, CM; Hoi, PM; Hou, T; Lee, SM; Li, CW; Li, S; Liang, W; Pan, P; Shen, M; Yu, H; Zhang, LQ; Zhou, ZY | 1 |
2 other study(ies) available for benzofuran and Parkinson Disease
Article | Year |
---|---|
Therapeutic Path to Double Knockout: Investigating the Selective Dual-Inhibitory Mechanisms of Adenosine Receptors A1 and A2 by a Novel Methoxy-Substituted Benzofuran Derivative in the Treatment of Parkinson's Disease.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Antiparkinson Agents; Benzofurans; Catalytic Domain; Computer Simulation; Drug Design; Humans; Ligands; Molecular Conformation; Parkinson Disease; Principal Component Analysis; Protein Binding; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P1; Structure-Activity Relationship; Thermodynamics | 2021 |
Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP⁺-induced oxidative stress and cell death in SH-SY5Y cells.
Topics: Acetamides; Alkanesulfonic Acids; Antioxidants; Benzofurans; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Discovery; Humans; Membrane Potential, Mitochondrial; Molecular Targeted Therapy; Oncogene Protein v-akt; Oxidants; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Pyridinium Compounds; rho-Associated Kinases; Signal Transduction; Thiadiazoles | 2014 |